- Home
- SLGN vs TMDX Comparison
SLGN vs TMDX Comparison
Compare SLGN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGN
- TMDX
- Stock Information
- Founded
- SLGN 1987
- TMDX 1998
- Country
- SLGN United States
- TMDX United States
- Employees
- SLGN N/A
- TMDX N/A
- Industry
- SLGN Containers/Packaging
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SLGN Industrials
- TMDX Health Care
- Exchange
- SLGN Nasdaq
- TMDX Nasdaq
- Market Cap
- SLGN 4.5B
- TMDX 3.9B
- IPO Year
- SLGN 1997
- TMDX 2019
- Fundamental
- Price
- SLGN $42.88
- TMDX $116.29
- Analyst Decision
- SLGN Strong Buy
- TMDX Buy
- Analyst Count
- SLGN 9
- TMDX 11
- Target Price
- SLGN $62.22
- TMDX $125.40
- AVG Volume (30 Days)
- SLGN 1.1M
- TMDX 959.0K
- Earning Date
- SLGN 10-29-2025
- TMDX 10-27-2025
- Dividend Yield
- SLGN 1.87%
- TMDX N/A
- EPS Growth
- SLGN N/A
- TMDX 2163.11
- EPS
- SLGN 2.81
- TMDX 2.02
- Revenue
- SLGN $6,162,113,000.00
- TMDX $531,292,000.00
- Revenue This Year
- SLGN $11.86
- TMDX $38.87
- Revenue Next Year
- SLGN $2.75
- TMDX $20.70
- P/E Ratio
- SLGN $15.20
- TMDX $56.43
- Revenue Growth
- SLGN 5.49
- TMDX 48.09
- 52 Week Low
- SLGN $41.30
- TMDX $55.00
- 52 Week High
- SLGN $58.14
- TMDX $145.50
- Technical
- Relative Strength Index (RSI)
- SLGN 39.28
- TMDX 46.60
- Support Level
- SLGN $41.30
- TMDX $109.77
- Resistance Level
- SLGN $43.31
- TMDX $119.78
- Average True Range (ATR)
- SLGN 0.73
- TMDX 4.84
- MACD
- SLGN 0.22
- TMDX -0.19
- Stochastic Oscillator
- SLGN 52.30
- TMDX 21.93
About SLGN Silgan Holdings Inc.
Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.